Objectives. We examined the prognostic significance of concentric remodeling of the left ventricle in patients with essential hypertension and normal left ventricular mass on echocardiography.
In essential hypertension, the risk of future cardiovascular complications is greater in patients with left ventricular hypertrophy at echocardiography than in those with normal left ventricular mass (1, 2) . The direct association over a wide range between left ventricular mass and incidence of cardiovascular morbid events (3, 4) suggests that even subtle changes in ventricular mass within the normal range might be predictive of increased cardiovascular risk. In this setting, some observa-tions suggest that a more complete definition of left ventricular geometry might be a promising approach to improve cardiovascular risk stratification in hypertension. In a long-term prospective study in hypertensive patients, Koren at al. (2) found that the risk of cardiovascular morbid events in subjects with left ventricular concentric remodeling (i.e., echocardiographic left ventricular mass <125 g/m 2 and thickness of the posterior wall divided by the left ventricular radius at enddiastole ->0.45) was intermediate between those with normal left ventricular mass and geometry and those with ventricular mass >125 g/m 2. Prevalence of left ventricular remodeling in hypertensive subjects with normal ventricular mass ranged between 16% (5) and 19% (6) in clinical studies where remodeling was defined solely by the relative thickening of the posterior wall but increased to up to 39% when the definition also included isolated thickening of the interventricular septurn (6) .
The present study was conducted in patients with essential hypertension and normal left ventricular mass at echocardiography at the time of their initial diagnostic studies in the absence of therapy. Subjects were obtained from the PIUMA database (Progetto Ipertensione Umbria Monitoraggio Ambulatoriale), an observational registry of morbidity and mortality in hypertensive subjects whose initial evaluation included noninvasive ambulatory blood pressure monitoring according to a standardized protocol (6, 7) . We compared the outcome of patients with normal left ventricular geometry with that of patients with concentric left ventricular remodeling in terms of cardiovascular morbid event rate over the subsequent years.
Methods
Study patients. The study group was composed of 694 consecutive hypertensive subjects included in the PIUMA registry (6) up to July 1993 who fulfilled the two admission criteria of good quality echocardiographic tracings and normal left ventricular mass (see later). Hypertensive subjects were identified in a prevalently rural area by a group of general practitioners who referred all patients with high blood pressure to our centers. Excluded from the present study, although included in the PIUMA registry over the same period, were 240 patients with left ventricular mass ->125 g/m 2, 253 patients with echocardiographic tracings of inadequate quality to determine ventricular mass and 109 patients who did not perform the echocardiographic study for administrative reasons.
Admission criteria to the PIUMA registry included all of the following: 1) essential hypertension with sitting blood pressure ->140 mm Hg systolic or 90 mm Hg diastolic on at least three visits in the last 3 weeks; 2) any previous antihypertensive drugs withdrawn for ->4 weeks; 3) agreement within 5 mm Hg between mercury column and automatic recorder in at least three consecutive measurements taken simultaneously on the same arm before beginning ambulatory blood pressure monitoring; 4) at least one valid ambulatory blood pressure reading/ hr; 5) absence of heart failure, valvular defects or concomitant important disease. The initial evaluation of all these subjects included a detailed medical history, 12-lead electrocardiogram (ECG), funduscopic evaluation, screening laboratory tests (urinalysis and determination of serum levels of urea nitrogen, creatinine, glucose, uric acid, cholesterol, sodium, potassium and calcium) and a routine standard and Doppler echocardiographic study from October 1987. Diabetes mellitus was defined by any one of the following: a fasting blood glucose level >140 mg/dl, a random nonfasting blood glucose level >200 mg/dl or the use of an oral hypoglycemic agent or insulin.
All subjects gave oral or written, informed consent to the study, which was conducted in accordance with the declarations of Helsinki and Tokyo.
Eehocardiography. The M-mode echocardiographic study of the left ventricle was performed under two-dimensional echocardiographic control with the use of commercially available machines. All measurements were made at end-expiration at the onset of the QRS complex using the American Society of Echocardiography leading edge to leading edge criteria according to standard laboratory procedures described previously (8, 9) . Only tracings with optimal visualization of interfaces and showing simultaneous visualization of the septum, left ventricular internal diameter and posterior wall were considered adequate to determine left ventricular mass. Echocardiographic examinations were performed by two physicians (P.V., G.S.), and the tracings were read by two other investigators. The mean value from at least five measurements of the left ventricle per observer was computed. At the time of the echocardiographic examination, all involved investigators were unaware of patients' casual and ambulatory blood pressure values.
Left ventricular mass in grams was calculated by the formula introduced by Devereux et al. (10) : 0.80 × (1.04 × [(Septal thickness + Left ventricular internal diameter + Posterior wall thickness) 3 -(Left ventricular internal diameter)3]) + 0.6 g and normalized by body surface area. A normal left ventricular mass was defined as a mass <125 g/m 2 in both men and women. This partition value has been used in some prospective studies (1,2,4) of the independent prognostic value of echocardiographic left ventricular hypertrophy, two of which (2, 4) were performed in a mixed study group of men and women. A dividing line between absence and presence of left ventricular hypertrophy at echocardiography may also be drawn by using gender-specific height-adjusted values of left ventricular mass, as done in the Framingham Heart Study (3), or by using values of left ventricular mass normalized by height elevated by a power of 2.7, as recently suggested by de Simone et al. (11) . A Cornell voltage score >2.0 mV in women or >2.8 mV in men (12) defined left ventricular hypertrophy by standard 12-lead electrocardiography.
The two-dimensional echocardiographic study showed symmetric left ventricular contraction in all subjects; hence, left ventricular volumes were calculated from end-diastolic and end-systolic diameters by using the Teichholz formula (13), which proved accurate in the absence of regional abnormalities of contraction (14) . Stroke volume (End-diastolic -Endsystolic volume) and cardiac output (Stroke volume × Instantaneous heart rate) were subsequently normalized by body surface area to obtain stroke index and cardiac index. Total peripheral resistance was derived as (Mean blood pressure × 80)/Cardiac output, where mean blood pressure was calculated as [Diastolic blood pressure + (Systolic blood pressureDiastolic blood pressure)/3]. Blood pressure was measured during the echocardiographic examination by a standard mercury sphygmomanometer. End-systolic meridional wall stress was calculated by using the formula introduced and validated by Reicbek et al. (15) .
Endocardialfractional shortening, defined as [(End-diastolic diameter -End-systolic diameter)/End-diastolic diameter] × 100, was calculated according to Lutas et al. (16) as observed value and as a percent of the predicted value on the basis of the regression equation between meridional end-systolic stress and fractional shortening in a normotensive group of 121 subjects (6) .
Midwall fractional shortening was estimated by taking into account the migration toward the epicardium of midwall left ventricular fibers from end-diastole to end-systole; it was March 15, 1995:871-8 LEFT VENTRICULAR REMODELING IN HYPERTENSION expressed as observed value and as percent of predicted value according to the method reported by de Simone et al. (17) . Definition of groups. All patients examined in this study had a normal left ventricular mass (<125 g/m2). They were classified into two groups: normal left ventricular geometry and left ventricular concentric remodeling, the latter defined by the thickness of the septum or posterior wall divided by left ventricular radius ->0.45. This partition value has been previously reported in cross-sectional (5) and prospective (2) studies of the clinical significance of the different patterns of left ventricular adaptation to hypertension. We (6) recently proposed extending the use of this cutoff point to define patterns of isolated relative thickening of the interventricular septum, because this condition was associated with features suggesting increased cardiovascular risk.
Ambulatory blood pressure monitoring. Ambulatory blood pressure was recorded by using the SpaceLabs units 5200, 90202 and 90207 set to take a measurement every 15 min for 24 h. Reading, automated editing and analysis of data provided by the recorders were done by the ABP5600, ABP90204 and ABP90209 interfaces (SpaceLabs). Systolic readings >260 or <70 mm Hg, diastolic readings >150 or <40 mm Hg and pulse pressure readings >150 or <20 mm Hg were automatically discarded. The daytime period was defined as the time interval between 6 AM and 10 PM, and the nighttime period as that between 10 PM and 6 AM. The spontaneous day to day variability of 24-h, daytime and nighttime ambulatory blood pressure has previously been assessed in some of these patients (18) .
Clinical follow-up. After their initial diagnostic studies, all patients included in the PIUMA registry were followed up in the outpatient clinic of the referring hospital or by their family doctors and were treated with standard life-style and pharmacologic measures intended to reduce clinic blood pressure to <140/90 mm Hg. The PIUMA protocol recommends that, in the absence of universally established normative values on ambulatory blood pressure measures, therapeutic strategies should be based on clinic blood pressure. Ambulatory blood pressure data remained accessible to patients and their doctors but were unlikely to significantly influence therapeutic decisions because they were generally considered to be investigational findings of unproved clinical utility. Diuretic drugs, beta-adrenergic blocking agents, angiotensin-converting enzyme inhibitors, calcium channel blockers and alphal-blockers, alone or in various combinations, were the antihypertensive drugs most frequently used.
Evaluation of cardiovascular events. Telephone interviews were conducted to ascertain the incidence of major complications of hypertension. All interviews were conducted directly with the patient without knowledge of results of echocardiography and ambulatory blood pressure monitoring; they were followed by a clinical visit whenever the patient consented. Hospital record forms of patients who developed a cardiovascular event were reviewed in conference by the authors of this study.
The following definitions were used. Statistical analysis. We compared the two hypertensive groups (concentric remodeling and normal left ventricular geometry) in terms of cardiovascular morbidity expressed as the combined number of fatal plus nonfatal cardiovascular events over the follow-up period. Event rates are presented as the number of events per 100 patient-years based on the ratio of the observed number of events to the total number of patient-years of exposure. For the subjects who experienced multiple nonfatal events, the analysis included only the first event.
Survival curves were estimated using Kaplan-Meier (19) product limit method, and compared by the Mantel (20) (log-rank) test. The effect of prognostic factors on survival was evaluated by Cox semiparametric regression models (21) . The assumption of proportional hazard over time was verified before performing the analysis and was met by all covariates. The covariates included in the Cox models were age (<40 years, 40 to 60 years, >60 years), gender (female, male), diabetes (no, yes), mean office blood pressure, mean 24-h ambulatory blood pressure, left ventricular mass index and geometry (normal left ventricular geometry, concentric left ventricular remodeling). The assumption concerning risk linearity for office and ambulatory blood pressure was verified by visual inspection. Age was analyzed as a categoric variable because of the abrupt increase of risk after age 60 years, with consequent failure to pass a linearity test. Adjusted relative risks for the significant Cox model factors were calculated as the antilogarithm of the b i coefficient (exp bi). Ninety-five percent confidence intervals around the estimates of relative risk were obtained from the formula exp[b i _+ (1.96 × SE bi)], where SE is the standard error of b i.
The other comparisons between the groups were made by Student t test and chi-square test when appropriate. In two- 
Results
Clinical characteristics. Some clinical characteristics and indexes of disease severity in the overall population and in the two groups with normal left ventricular geometry and concentric left ventricular remodeling are reported in Table 1 . Prevalence of concentric remodeling was 39.2%. There were no differences in gender, height, weight, body surface area and body mass index between the two patient subsets. In contrast, patients with concentric remodeling were slightly older, had a longer duration of hypertension and a more frequent history of previous use of antihypertensive drugs (36.0% vs. 23.2%, p <
0.01).
Baseline office blood pressure and ambulatory blood pressure during the day and at night were definitely higher in the group with concentric left ventricular remodeling (all p < 0.01). The distribution of funduscopic changes and serum levels of glucose, creatinine and total, and high and low density lipoprotein cholesterol did not differ between the two groups. Serum triglycerides were slightly higher in the group with concentric remodeling (p < 0.05).
During follow-up, 59% of patients with normal left ventricular geometry were being treated with life-style measures alone, as opposed to 42% of patients with concentric left ventricular remodeling (p < 0.01). In contrast, the distribution of beta-blockers and diuretics, alone or combined, that of calcium channel blockers or angiotensin-converting enzyme inhibitors, alone or combined, and that of different drug combinations did not show any significant difference between the two groups (10%, 18% and 13%, respectively, in those with normal left ventricular geometry vs. 11%, 26% and 21% in those with concentric remodeling).
Left ventricular structure and function. Left ventricular mass, before and after indexing for body surface area, height or height elevated at the power of 2.7 (11), was greater in the subset with concentric left ventricular remodeling than in that with normal ventricular geometry ( Table 2) . Interventricular septum thickness and posterior wall thickness at end-diastole and end-systole were greater in the group with concentric remodeling (all p < 0.01), whereas end-diastolic and endsystolic diameters were greater in the group with normal geometry (both p < 0.01). Endocardial fractional shortening did not differ between the groups, whereas midwall fractional shortening was depressed in the group with concentric remodeling (p < 0.01). The ratios of observed to predicted endocardial and midwall fractional shortening were lower in the group with concentric remodeling than in the group with normal ventricular geometry (all p < 0.01). Total peripheral resistance was increased and cardiac index decreased in the subset with concentric remodeling (all p < 0.01). Meridional end-systolic wall stress was greater in the subset with normal ventricular geometry (p < 0.01). In 3.3% of subjects the Cornell voltage (R wave in lead aVE + S wave in lead V3) (12) was increased (>2.0 mV in women or >2.8 mV in men).
Cardiovascular morbidity. We obtained complete follow-up data from 686 (98.8%) of the 694 subjects who entered the study. The mean duration of follow-up was 2.71 years (range 0.1 to 7.7).
We documented 29 cardiovascular events (6 fatal and 23 nonfatal). In the group with normal left ventricular geometry, there were three patients with stroke, three with myocardial infarction, two with sudden cardiac death, three with transient ischemic attacks, one with coronary revascularization and two with occlusive peripheral vascular disease. In the group with concentric left ventricular remodeling there were four patients with stroke, two with myocardial infarction, one with sudden cardiac death, two with transient ischemic attacks, one with coronary revascularization, one with angina, one with newonset heart failure, two with occlusive peripheral vascular disease and one with progressive renal failure requiring dialysis. Overall, the distribution of antihypertensive treatments did not differ between the patients who did or did not have a cardiovascular morbid event. Thus, life-style measures; beta-blockers or diuretic drugs (alone or in combination); angiotensin-converting enzyme inhibitors (alone or in combination); or different drug combinations were used in 52%, 10%, 21% and 17%, respectively, of patients with an event versus 45%, 17%, 24% and 14% of those without events (p = 0.58).
Cardiovascular morbidity, expressed as the combined number of fatal and nonfatal events per 100 patient-years (Table 3) , was 1.53 in the overall study group, 1.12 in the group with normal left ventricular geometry and 2.39 in that with concentric left ventricular remodeling (Fig. 1, left panel) . Event-free survival curves (Fig. 1 , right panel) differed between the two groups (p = 0.024, log-rank test). After assessment of the independent association with several covariates (age, gender, diabetes, left ventricular mass index, mean clinic blood pressure and mean 24-h ambulatory blood pressure) in Cox proportional hazard models, the risk of cardiovascular morbid events {Table 4) was higher in the group with concentric remodeling than in that with normal geometry (relative risk 2.56; 95% confidence interval 1.20 to 5.45; p < 0.01). . Data refer to 694 subjects with essential hypertension and left ventricular mass < 125 g/m 2 on echocardiography who were followed up for -<7.7 years.
Discussion
Previous reports have suggested that echocardiography plays an important role in cardiovascular risk stratification in essential hypertension. For any given value of blood pressure and other risk factors for cardiovascular disease, cardiovascular morbidity and mortality are less in hypertensive patients with normal left ventricular mass on echocardiography than in those with left vcntricular hypertrophy (1,2). The Framingham Heart Study (3) clearly demonstrated the independent prognostic significance of echocardiographic left ventricular mass in a large general population sample. The new finding in the present study is that even in the presence of a normal left ventricular mass, the echocardiographic definition of left ventricular geometry (i.e., normal geometry vs. concentric remodeling) provides a further independent stratification of cardiovascular risk in relatively healthy unselected patients with essential hypertension. Cardiovascular morbidity was consistently higher in the group with concentric remodeling than in that with normal ventricular geometry, and the prognostic value of this categorization persisted after assessment of the independent effect of several covariates including age, gender, diabetes, left ventricular mass index, clinic blood pressure and average 24-h ambulatory blood pressure. Prognostic significance of left ventricular remodeling in hypertension. In a 10-year observational study in hypertensive patients, Koren et al. (2) found a rate of cardiovascular morbid events of 1.8/100 patient-years in 150 patients with normal left ventricular geometry and of 4.2/100 patient-years in 34 patients with concentric left ventricular remodeling. However, the small sample size precluded a multivariate assessment of the prognostic significance of left ventricular geometric patterns in the subgroup with normal ventricular mass (2) . The present study confirms and extends those findings to a larger patient group with essential hypertension and normal left ventricular mass at echocardiography (422 patients with normal ventricular geometry and 272 patients with concentric remodeling), all of whom were untreated at the time of their initial diagnostic evaluation. Although the duration of follow-up was shorter in our study than in that of Koren et al. (2) , our sample size was adequate to detect prognostic differences between the subgroup with normal ventricular geometry and that with concentric ventricular remodeling. The difference in cardiovascular morbidity between the two groups remained statistically significant after adjustment for several covariates, including average 24-h ambulatory blood pressure, a measure of blood pressure currently held superior to clinic blood pressure in predicting target organ damage (8, 22) and future cardiovascular complications (7, (23) (24) (25) (26) of hypertension. At variance with Koren et al. (2) , who defined concentric left ventricular remodeling solely on the basis of relative thickening of the posterior wall, we separated patients with isolated relative thickening of the interventricular septum from those with normal left ventricular geometry and included these patients in the group with ventricular remodeling. Using the Cornell definition of relative wall thickness reported by Koren et al. (2), we calculated the prevalence of the different patterns of left ventricular geometry in our overall hypertensive group, including 240 subjects with left ventricular mass >125 g/m 2, and found a 61% prevalence (570 subjects) of normal left ventricular geometry, a 13.3% prevalence (124 subjects) of concentric left ventricular remodeling, a 14.3% prevalence of eccentric left ventricular hypertrophy and an 11.3% prevalence of concentric left ventricular hypertrophy. Corresponding figures in the study of Koren et al. (2) were similar (59.3%, 13.4%, 15.8% and 11.5%, respectively). Even the prevalence of left ventricular hypertrophy was comparable in our overall hypertensive group (26%) and in the Cornell series (27%) (2) . As assessed by using the Cornell definition of relative wall thickness (2), the rate of cardiovascular morbid events in our group with normal left ventficular geometry was 1.5/100 patients per year, vs. 1.6/100 patients per year in the group with concentric remodeling (log-rank test: p = 0.062).
Thus, by moving persons at slightly increased risk from the group with normal geometry to that with concentric remodeling, the present definition of concentric remodeling may have improved cardiovascular risk stratification in hypertensive subjects with normal left ventricular mass. A previous study from our laboratory showed that asymmetric ventricular remodeling due to isolated septal thickening in hypertensive subjects with normal ventricular mass was associated with a greater clinic and ambulatory blood pressure and left ventricular mass, and other features suggested an increased cardiovascular risk in these subjects (6) .
Patients with concentric left ventricular remodeling were older and had a longer known duration of hypertension, an increased clinic and ambulatory blood pressure and slightly higher levels of serum triglycerides than did the patients with normal ventricular geometry. On echocardiography, they had greater septal and posterior wall thickness, smaller internal diameter, greater left ventricular mass and a depressed contractile performance as assessed by using either the midwall fractional shortening or the ratio of observed to predicted fractional shortening, both endocardial and midwall. In addition, they had a decrease in cardiac index with increased total peripheral resistance despite reduced end-systolic stress. The reliability of left ventricular volumes calculated by using the Teichholz formula may be limited in our conditions by the different minor/major left ventricular axis relation in the two groups. However, all these findings concur in showing that concentric left ventricular remodeling is an important echocardiographic finding that should be searched for and considered as a marker of increased cardiovascular risk in hypertensive patients with normal left ventricular mass. We rule out the possibility that the use of 125 g/m 2 as a partition value between normal ventricular mass and ventricular hypertrophy in both men and women may have produced the inclusion of a significant number of women with left ventricular hypertrophy based on gender-specific criteria into the group with concentric remodeling. In fact, there were only 33 women with left ventricular mass between 110 g/m 2 (27) and 125 g/m 2 (and only one event among them) in the group of 143 women (with six events) with concentric remodeling.
The mechanisms by which concentric left ventricular remodeling may predispose patients without echocardiographic left ventricular hypertrophy to cardiovascular morbid events cannot be assumed from our study. The excess risk associated with concentric left ventricular remodeling persisted over time despite standard antihypertensive therapy. More patients with normal left ventricular geometry than with concentric left ventricular remodeling received nonpharmacologic measures, but the distribution of the various classes of antihypertensive drugs in those who received therapy did not differ between these two groups or between the subjects who experienced an event and those who did not. The low event rate in our patient group (1.53 events/100 patient-years) and the relatively low duration of follow-up were compatible with a modest predicted effect on outcome by antihypertensive therapy, as suggested by results of large trials in mild hypertension (28, 29) .
It is tempting to speculate that concentric left ventricular remodeling might represent a distinct entity of an early stage of development of left ventricular hypertrophy, as suggested for example by the findings of increased left ventricular mass, duration of hypertension and age in these subjects.
Conclusions. From this study we conclude that concentric remodeling of the left ventricle, defined by the thickness of the septum or posterior wall divided by the left ventricular radius at end-diastole >-0.45, is an important independent predictor of increased cardiovascular risk in hypertensive subjects with normal (<125 g/m e) left ventricular mass. Additional studies are needed to determine whether effective antihypertensive treatment may be accompanied by restoration of a normal left ventricular geometric pattern and whether this effect may have implications for cardiac function and prognosis. Further research issues are the clinical feasibility and etficacy of more intensive use of life-style measures and deferral of drug treatment over time in hypertensive subjects with normal left ventricular geometry on echocardiography who have no other cardiovascular risk factors.
